Literature DB >> 21410606

An approach to the patient with retiform purpura.

Ashley Wysong1, Priya Venkatesan.   

Abstract

Retiform purpura consists of branching purpuric lesions caused by a complete blockage of blood flow in the dermal and subcutaneous vasculature. The differential diagnosis for retiform purpura is broad, including vasculitides of the small and medium vessels as well as microvascular occlusion due to thrombotic, infectious, and embolic phenomena. Determining the etiology of this important dermatologic sign can be a diagnostic challenge; however, an organized approach can improve the speed and accuracy of diagnosis and identify an effective treatment. This review focuses on early recognition, evaluation, and treatment of hospitalized patients with retiform purpura. Specifically, vasculitis, protein C and S deficiencies, heparin necrosis, warfarin necrosis, antiphospholipid antibody syndrome, disseminated intravascular coagulation, cryoglobulinemia, calciphylaxis, and cholesterol embolization syndrome will be discussed in detail. These conditions are commonly seen in consultative dermatology and can have multiorgan involvement, complicated laboratory evaluation, and long-term therapeutic implications.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21410606     DOI: 10.1111/j.1529-8019.2011.01392.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  8 in total

1.  Acute retiform purpura caused by Morganella morganii.

Authors:  Rebeca Calado; Maria Relvas; Maria Manuel Brites; José Carlos Cardoso
Journal:  BMJ Case Rep       Date:  2019-12-23

2.  Widespread cutaneous vasculopathy associated with levamisole-adulterated cocaine.

Authors:  Alba Sánchez-Velázquez; Alba Calleja-Algarra; Virginia Velasco-Tamariz; Carlos Zarco-Olivo
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

Review 3.  Pigmented purpura and cutaneous vascular occlusion syndromes.

Authors:  Ana Cecilia Lamadrid-Zertuche; Verónica Garza-Rodríguez; Jorge de Jesús Ocampo-Candiani
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

4.  Skin manifestations associated with systemic diseases - Part I.

Authors:  Ana Luisa Sampaio; Aline Lopes Bressan; Barbara Nader Vasconcelos; Alexandre Carlos Gripp
Journal:  An Bras Dermatol       Date:  2021-09-17       Impact factor: 1.896

Review 5.  The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.

Authors:  Gehan A Pendlebury; Peter Oro; William Haynes; Drew Merideth; Samantha Bartling; Michelle A Bongiorno
Journal:  Dermatopathology (Basel)       Date:  2022-06-29

6.  Pressure-induced necrosis can mimic retiform purpura.

Authors:  Ellen Melrose; Leah Laageide; Krishna Mutgi; Mary S Stone; Karolyn A Wanat
Journal:  JAAD Case Rep       Date:  2018-04-04

7.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.

Authors:  Cynthia Magro; J Justin Mulvey; David Berlin; Gerard Nuovo; Steven Salvatore; Joanna Harp; Amelia Baxter-Stoltzfus; Jeffrey Laurence
Journal:  Transl Res       Date:  2020-04-15       Impact factor: 7.012

8.  Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection.

Authors:  M Brito Caldeira; M Pestana; A L João; C Fernandes; A João; N Cunha
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-08-04       Impact factor: 9.228

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.